Ronald Bleday, MD, Appointed Associate Chair for Quality and Patient Safety

Ronald Bleday, MD, has been appointed associate chair for Quality and Patient Safety in the Department of Surgery. Dr. Bleday will lead and enable safe and efficient approaches to inpatient surgical care at Brigham Health and will be responsible for optimizing the quality and safety of inpatient care provided by practitioners in the Department of Surgery at Brigham and Women’s Hospital (BWH) and Brigham and Women’s-Faulkner Hospital (BWFH).

Ronald Bleday, MD

Ronald Bleday, MD
Associate Chair for Quality and Patient Safety, Department of Surgery, Brigham and Women’s Hospital
Section Chief, Colon and Rectal Surgery, Brigham and Women’s Hospital
Associate Professor of Surgery, Harvard Medical School

Ronald Bleday, MD, is section chief of the Division of Colorectal Surgery and program director for the Colorectal Fellowship at Brigham and Women’s Hospital (BWH) and Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). In addition, he is an associate professor of surgery at Harvard Medical School.

Dr. Bleday received his medical degree from McGill University School of Medicine, completed a General Surgery Residency at Brown University School of Medicine and a Surgery and Trauma Residency at Rhode Island Hospital. He completed his Surgical Oncology Fellowships at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and New England Deaconess Hospital/Harvard Surgical Service, his Surgical Endoscopy Fellowship at Massachusetts General Hospital and his Colon and Rectal Surgery Fellowship at the University of Minnesota.

He currently serves as secretary of the Research Foundation of the American Society of Colon and Rectal Surgeons (ASCRS) and as a member of the Nation Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee’s (GISC) Rectal Anal Task Force.

The author of over 50 peer-reviewed publications, Dr. Bleday’s research focuses on the American College of Surgeons Oncology Group (ASCOSOG) local excision study, stool-based biomarker research, laparoscopic vs. open colectomy and tumor bank accrual. He worked on implementing Enhanced Recovery After Surgery (ERAS) and Surgical Site Infection (SSI) reduction protocols at BWH and is part of the Executive Committee of the Partners Colorectal Surgery Collaborative.

Dr. Bleday has clinical interests in anorectal surgery, cancer surgery, colon disease and surgery, Crohn’s disease, diverticular disease, laparoscopic surgery, rectal surgery, sphincter sparing surgery and ulcerative colitis.